Beneficient Granted Listing Extension by Nasdaq

Core Viewpoint - Beneficient has received approval from the Nasdaq Hearings Panel to continue its listing on Nasdaq, contingent upon the company meeting certain compliance requirements, including filing delayed reports and maintaining a minimum bid price of $1.00 per share [1]. Group 1: Compliance and Reporting - The company is actively working with its auditor to complete and file the Delayed Reports, which include the Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 [2]. - If the company fails to regain compliance with the bid price requirement, it plans to seek stockholder approval for a reverse stock split to meet the $1.00 bid price requirement for a minimum of 10 consecutive trading days [2]. Group 2: Company Overview - Beneficient aims to democratize the global alternative asset investment market by providing solutions to mid-to-high net worth individuals, small-to-midsized institutions, and General Partners seeking exit options and capital solutions [3]. - The company's proprietary online platform, AltAccess, allows customers to explore exit options and receive proposals securely [3]. Group 3: Regulatory Framework - Beneficient Fiduciary Financial, L.L.C., a subsidiary of the company, has received its charter under the State of Kansas' Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight [4].